Uppdrag | 14 Nov 2014

Setterwalls advised Recipharm in connection with SEK 1 billion acquisition of Lusomedicameta

Responsive image

Setterwalls was the legal advisor for Recipharm AB (publ) in connection with the SEK 1 billion acquisition of Lusomedicameta Sociedade Técnica Farmacêutica S.A., a Lisbon based CDMO company. The equity consideration has been paid in a combination of cash and new issued shares.

Kontakt:

Verksamhetsområde:

Mergers & Acquisitions

  • This field is for validation purposes and should be left unchanged.

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.